Techne Corp Stock as Big Money Enter, Sentiment at 1.32

June 29, 2018 - By Lena Young

Bio-Techne Corporation (NASDAQ:TECH) Corporate Logo

Techne Corp’s Sentiment

“Big money sentiment for Techne Corp (NASDAQ:TECH) in Q1 2018 increased to 1.32, according to Securities and Exchange Commission filings. That’s up 0.34, from 2017Q4’s 0.98. 136 hedge funds opened new or increased equity positions, while 103 sold and decreased positions in Techne Corp so the sentiment increased. Funds own 35.01 million shares, down from 35.53 million shares in 2017Q4. Funds holding Techne Corp in top 10 increased from 2 to 4 for an increase of 2. 14 Investors Sold All; 89 Reduced Holdings; 83 increased holdings while 53 hedge funds bought holdings.

Largest Techne Corp Investors

As of Q1 2018 Sandhill Capital Partners Llc has 3.74% invested in Techne Corp. As of Q1 2018, 1.99 million shares of Techne Corp are owned by Brown Capital Management Llc. Summit Creek Advisors Llc reported 119,419 shares. Stone Run Capital Llc revealed 37,325 shares position in Techne Corp. The Minnesota-based fund Mairs & Power Inc looks positive on Techne Corp, owning 1.38 million shares.

Bio-Techne Corporation, together with its subsidiaries, develops, makes, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide.The firm is worth $5.55 billion. It operates through three divisions: Biotechnology, Protein Platforms, and Diagnostics.49.89 is the P/E ratio. The Biotechnology segment offers native and recombinant proteins, monoclonal and polyclonal antibodies, immunoassays, biologically active chemical compounds, and in situ genomic hybridization assays for the research and clinical diagnostics markets.

TECH is touching $147.66 during the last trading session, after increased 0.36%.Bio-Techne Corporation has volume of 69,650 shares. Since June 29, 2017 TECH has risen 33.83% and is uptrending. TECH outperformed by 21.26% the S&P 500.

On August, 14 is awaited Bio-Techne Corporation (NASDAQ:TECH)’s earnings report, as reported by RTT. Analysts expect change of 15.69 % or $0.16 from previous year’s $1.02 earnings per share compared to current’s $1.18 earnings per share. If earnings per share of $1.18 is announced the profit of TECH could hit $44.34M giving it 31.28 P/E. 4.42 % EPS growth is what analysts predict. $1.13 earnings per share was announced for last quarter.

174,377 are owned by Sei Invs Company. Sit Investment stated it has 7,225 shs. Btim has invested 0.32% of its capital in Bio-Techne Corporation (NASDAQ:TECH). Wellington Mngmt Gru Limited Liability Partnership holds 0.01% or 171,660 shs in its capital. Vanguard Grp Incorporated invested in 0.02% or 3.20M shs. 8,280 are held by Amalgamated Commercial Bank. Bnp Paribas Arbitrage invested in 9,743 shs. Northern Trust reported 379,422 shs. Shelton Mngmt invested in 2,648 shs. Aqr Capital Mngmt Ltd Company reported 0.01% in Bio-Techne Corporation (NASDAQ:TECH). Neuberger Berman Group Limited Liability Corporation reported 1.65 million shs. 3,145 were reported by Caprock Group Inc. Us Commercial Bank De holds 54,848 shs. 35,174 are held by Aperio Group Ltd Limited Liability Company. Loring Wolcott And Coolidge Fiduciary Advisors Ltd Liability Partnership Ma reported 0% in Bio-Techne Corporation (NASDAQ:TECH).

Bio-Techne Corporation had 3 selling transactions and 0 buys since February 13, 2018. This’s net activity of $2.13 million. On Thursday, June 7 $1.28M worth of stock was sold by Kummeth Charles R.. Dinarello Charles A sold $680,303 worth of Bio-Techne Corporation (NASDAQ:TECH) or 5,000 shs on Tuesday, February 13.

Bio-Techne Corporation (NASDAQ:TECH) Ratings Coverage

A total of 6 analysts rate Bio-Techne Corporation (NASDAQ:TECH) as follows: 4 “Buy”, 2 “Hold” and 0 “Sell”. Тherefore 67% are bullish. (NASDAQ:TECH) has 9 ratings reports on 29 Jun 2018 according to StockzIntelligence. On Thursday, March 1 the stock has “Buy” rating by Deutsche Bank. On Wednesday, June 27 Deutsche Bank downgraded the shares of TECH in report to “Hold” rating. In Thursday, January 18 report Robert W. Baird maintained it with “Buy” rating and $154.0 target. On Thursday, May 3 the firm earned “Buy” rating by Deutsche Bank. The stock rating was maintained by Robert W. Baird with “Buy” on Tuesday, February 6. On Wednesday, February 7 the stock of Bio-Techne Corporation (NASDAQ:TECH) earned “Hold” rating by Stephens. On Thursday, May 3 the company was maintained by Leerink Swann. On Wednesday, February 7 Craig Hallum maintained Bio-Techne Corporation (NASDAQ:TECH) with “Buy” rating.

For more Bio-Techne Corporation (NASDAQ:TECH) news published recently go to: Streetinsider.com, Investingnews.com, Investingnews.com, Investingnews.com or Investingnews.com. The titles are as follows: “Bio-Techne (TECH) to Acquire Quad Technologies” published on June 07, 2018, “Adesto Announces Agreement to Acquire Echelon” on June 29, 2018, “JA Solar Supplies Half-Cell Modules for Solar Plant in Africa” with a publish date: June 29, 2018, “Cinedigm Expands its Digital-First Channel” and the last “Blockchain Opportunities to Surpass US$2.5 Trillion, Report Says” with publication date: June 28, 2018.

Bio-Techne Corporation (NASDAQ:TECH) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.